These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6075585)

  • 1. Effect of DL-2(p-aminophenyl)-2-phenylethylamine on adrenocortical function in Cushing's syndrome due to nontumorous adrenocrotical hyperfunction.
    Gabrilove JL; Nicolis GL; Gallagher TF
    J Clin Endocrinol Metab; 1967 Nov; 27(11):1550-7. PubMed ID: 6075585
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of d-2(p-aminophenyl)-2-phenylethylamine (SK&F-12185) in Cushing's syndrome associated with adrenocortical carcinoma.
    Gabrilove JL; Nicolis GL; Gallagher TF
    Metabolism; 1968 Oct; 17(10):936-42. PubMed ID: 4877990
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of SK&F-12185 [dl-2(p-aminophenyl)-2-phenylethylamine] on adrenocortical function in primary aldosteronism.
    Gabrilove JL; Nicolis GL; Gallagher TF
    J Clin Endocrinol Metab; 1967 Sep; 27(9):1337-40. PubMed ID: 6038874
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of aminoglutethimide upon adrenal function and cortisol metabolism in Cushing's syndrome.
    Schteingart DE; Conn JW
    J Clin Endocrinol Metab; 1967 Dec; 27(12):1657-66. PubMed ID: 6060954
    [No Abstract]   [Full Text] [Related]  

  • 5. Remission in Cushing's syndrome with o,p'-DDD.
    Southren AL; Tochimoto S; Strom L; Ratuschni A; Ross H; Gordon G
    J Clin Endocrinol Metab; 1966 Mar; 26(3):268-78. PubMed ID: 4286017
    [No Abstract]   [Full Text] [Related]  

  • 6. [Our experience with o,p'-DDD in the treatment of hypercorticism].
    Mathieu De Fossey B; Luton JP; Bricaire H
    Ann Endocrinol (Paris); 1968; 29(1):93-102. PubMed ID: 4872638
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of tumorous adrenal hyperfunction by aminoglutethimide.
    Smilo RP; Earll JM; Forsham PH
    Metabolism; 1967 Apr; 16(4):374-7. PubMed ID: 4290376
    [No Abstract]   [Full Text] [Related]  

  • 8. [Change in the content of steroid hormones in the urine and blood plasma in Itsenko-Cushing's disease under the action of drug preparations].
    Skvortsova RI
    Ter Arkh; 1974; 46(12):90-5. PubMed ID: 4454030
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of aminoglutethimide in a case of ectopic ACTH syndrome. Influence on steroid metabolism.
    McMillan M; Maisey MN
    Acta Endocrinol (Copenh); 1970 Aug; 64(4):676-86. PubMed ID: 4318105
    [No Abstract]   [Full Text] [Related]  

  • 10. Cushing's syndrome due to bilateral adrenocortical hyperplasia caused by a benign adrenal medullary tumor.
    Meloni CR; Tucci J; Canary JJ; Kyle LH
    J Clin Endocrinol Metab; 1966 Nov; 26(11):1192-200. PubMed ID: 4288612
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of an adrenal 11-beta, 17-alpha hydroxylase inhibitor in juvenile-onset diabetes mellitus.
    Narduzzi JV; Sabeh G; Weir TF; Cleary WJ; Danowski TS
    Clin Pharmacol Ther; 1967; 8(5):684-91. PubMed ID: 4293304
    [No Abstract]   [Full Text] [Related]  

  • 12. UNUSUAL CASE OF ADRENOCORTICAL HYPERFUNCTION.
    DEMOOR P; ROELS H; DELAERE K; CRABBE J
    J Clin Endocrinol Metab; 1965 May; 25():612-20. PubMed ID: 14313755
    [No Abstract]   [Full Text] [Related]  

  • 13. Cushing's syndrome. An evaluation of the clinical usefulness of urinary free cortisol and other urinary steroid measurements in diagnosis.
    Burke CW; Beardwell CG
    Q J Med; 1973 Jan; 42(165):175-204. PubMed ID: 4688791
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inhibition of adrenocortical steroid production in therapy].
    Bricaire H; Philbert M; Luton JP
    Rev Fr Etud Clin Biol; 1968; 13(6):563-7. PubMed ID: 4178146
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of endocrine factors in the genesis of otosclerosis].
    Kostrov NI; Kiselev
    Zh Ushn Nos Gorl Bolezn; 1970; 30(1):26-31. PubMed ID: 5424108
    [No Abstract]   [Full Text] [Related]  

  • 16. Patterns of urinary excretion of steroids in Cushing's syndrome.
    Martin MM; Hamman BL
    J Clin Endocrinol Metab; 1966 Mar; 26(3):257-67. PubMed ID: 4286016
    [No Abstract]   [Full Text] [Related]  

  • 17. Malignant melanoma with ectopic production of adrenocorticotropic hormone. Palliative treatment with inhibitors of adrenal steroid biosynthesis.
    Carey RM; Orth DN; Hartmann WH
    J Clin Endocrinol Metab; 1973 Mar; 36(3):482-7. PubMed ID: 4119547
    [No Abstract]   [Full Text] [Related]  

  • 18. [Determination of urinary steroids in adrenocortical hyperfunction].
    JAKOBSON T
    Duodecim; 1959; 75():808-17. PubMed ID: 13853081
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of modified stimulation test in the diagnosis of adrenal cortex diseases].
    Konopka P; Morawek A; Religa Z
    Pol Arch Med Wewn; 1969 Jul; 43(1):1025-34. PubMed ID: 4310037
    [No Abstract]   [Full Text] [Related]  

  • 20. Cushing's syndrome secondary to a benign paraganglioma.
    Cardenas F; Coffey RJ; Meloni R
    Am Surg; 1970 May; 36(5):283-9. PubMed ID: 4314687
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.